Open Access
Correction: Girard et al. Comparative Efficacy of Neoadjuvant Nivolumab Plus Chemotherapy versus Conventional Comparator Treatments in Resectable Non-Small-Cell Lung Cancer: A Systematic Literature Review and Network Meta-Analysis. Cancers 2024, 16, 2492
Nicolas Girard
1, 2
,
Mariam Besada
3
,
Basia Rogula
3
,
Stefano Lucherini
4
,
Lien Vo
5
,
Mohammad A Chaudhary
5
,
S M Goring
3
,
Greta Lozano Ortega
3
,
Mia Tran
5
,
Nebibe Varol
4
,
Nathalie Waser
6
,
Winifred W Yu
6
,
Jay M. Lee
7
,
Jonathan Spicer
8
2
3
Broadstreet HEOR, Vancouver, BC V6A 1A4, Canada
|
4
Bristol Myers Squibb, Uxbridge UB8 1DH, UK
|
6
ICON Plc, Burlington, ON L7N 3G2, Canada
|
Publication type: Journal Article
Publication date: 2025-02-17
Abstract
Winifred W. Yu was not included as an author in the original publication [...]
Found
Nothing found, try to update filter.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
0
Total citations:
0
Cite this
GOST |
RIS |
BibTex |
MLA
Cite this
GOST
Copy
Girard N. et al. Correction: Girard et al. Comparative Efficacy of Neoadjuvant Nivolumab Plus Chemotherapy versus Conventional Comparator Treatments in Resectable Non-Small-Cell Lung Cancer: A Systematic Literature Review and Network Meta-Analysis. Cancers 2024, 16, 2492 // Cancers. 2025. Vol. 17. No. 4. p. 674.
GOST all authors (up to 50)
Copy
Girard N., Besada M., Rogula B., Lucherini S., Vo L., Chaudhary M. A., Goring S. M., Lozano Ortega G., Tran M., Varol N., Waser N., Yu W. W., Lee J. M., Spicer J. Correction: Girard et al. Comparative Efficacy of Neoadjuvant Nivolumab Plus Chemotherapy versus Conventional Comparator Treatments in Resectable Non-Small-Cell Lung Cancer: A Systematic Literature Review and Network Meta-Analysis. Cancers 2024, 16, 2492 // Cancers. 2025. Vol. 17. No. 4. p. 674.
Cite this
RIS
Copy
TY - JOUR
DO - 10.3390/cancers17040674
UR - https://www.mdpi.com/2072-6694/17/4/674
TI - Correction: Girard et al. Comparative Efficacy of Neoadjuvant Nivolumab Plus Chemotherapy versus Conventional Comparator Treatments in Resectable Non-Small-Cell Lung Cancer: A Systematic Literature Review and Network Meta-Analysis. Cancers 2024, 16, 2492
T2 - Cancers
AU - Girard, Nicolas
AU - Besada, Mariam
AU - Rogula, Basia
AU - Lucherini, Stefano
AU - Vo, Lien
AU - Chaudhary, Mohammad A
AU - Goring, S M
AU - Lozano Ortega, Greta
AU - Tran, Mia
AU - Varol, Nebibe
AU - Waser, Nathalie
AU - Yu, Winifred W
AU - Lee, Jay M.
AU - Spicer, Jonathan
PY - 2025
DA - 2025/02/17
PB - MDPI
SP - 674
IS - 4
VL - 17
SN - 2072-6694
ER -
Cite this
BibTex (up to 50 authors)
Copy
@article{2025_Girard,
author = {Nicolas Girard and Mariam Besada and Basia Rogula and Stefano Lucherini and Lien Vo and Mohammad A Chaudhary and S M Goring and Greta Lozano Ortega and Mia Tran and Nebibe Varol and Nathalie Waser and Winifred W Yu and Jay M. Lee and Jonathan Spicer},
title = {Correction: Girard et al. Comparative Efficacy of Neoadjuvant Nivolumab Plus Chemotherapy versus Conventional Comparator Treatments in Resectable Non-Small-Cell Lung Cancer: A Systematic Literature Review and Network Meta-Analysis. Cancers 2024, 16, 2492},
journal = {Cancers},
year = {2025},
volume = {17},
publisher = {MDPI},
month = {feb},
url = {https://www.mdpi.com/2072-6694/17/4/674},
number = {4},
pages = {674},
doi = {10.3390/cancers17040674}
}
Cite this
MLA
Copy
Girard, Nicolas, et al. “Correction: Girard et al. Comparative Efficacy of Neoadjuvant Nivolumab Plus Chemotherapy versus Conventional Comparator Treatments in Resectable Non-Small-Cell Lung Cancer: A Systematic Literature Review and Network Meta-Analysis. Cancers 2024, 16, 2492.” Cancers, vol. 17, no. 4, Feb. 2025, p. 674. https://www.mdpi.com/2072-6694/17/4/674.